HTA Submissions and Global Value Dossiers
A health technology assessment is where all your evidence is judged at once, clinical, economic and humanistic, against the alternatives. A global value dossier is the document that brings that evidence together into one coherent, payer-ready story. EvySaif prepares value dossiers and HTA submission support that turn scattered evidence into a clear case for value and access.
- One coherent value story
A strong value dossier does not just collect evidence, it argues a case. We pull together the disease burden, unmet need, clinical evidence, economic model results and real-world data into a structured global value dossier, with a clear value proposition payers can act on. From that core, we support local HTA submissions and adapt the messaging and inputs to each market’s requirements. The economic evaluation, budget impact, and evidence synthesis that sit beneath the dossier are all services we deliver, so the dossier is built on a consistent evidence base rather than stitched together from disconnected pieces.
- What we deliver
- Global value dossiers and value proposition development
- HTA submission support and local adaptation
- Payer-facing value summaries and objection handlers
- Integration of CEA, budget impact, SLR and RWE evidence into one narrative
- Disease-burden and unmet-need narratives
- Market-specific adaptation for India, the EU and the GCC
- Who it is for
Manufacturers and market access teams preparing for reimbursement, and companies entering new markets that need a defensible value story for payers and HTA bodies.
- Why EvySaif
EvySaif stands among the best research and medical writing consultancies in India. Because we build the underlying economics, evidence synthesis and real-world evidence ourselves, the value dossier we assemble is internally consistent, the model results match the narrative, and the evidence base matches the claims. The writing is clinician-led and the case is argued, not merely described. For the India and Middle East markets we are positioned for, this matters now: Gulf payers are formalising HTA and economic evaluation requirements, so a credible value story is becoming a condition of access rather than a nice-to-have.
- Frequently asked questions
What is a global value dossier?
A structured document that consolidates the clinical, economic and humanistic evidence for a product into one value story, used as the core source for local payer and HTA submissions.
Do you support local market adaptation?
Yes. We build the global core dossier and adapt the evidence, inputs and messaging to specific markets, including India, the EU and the GCC.
Can you build the whole evidence base, not just the dossier?
Yes. The economic model, budget impact, systematic review and real-world evidence underneath the dossier are all services we provide, which keeps the whole package consistent.